Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS

Journal of the American Academy of Dermatology

Volumn 50, Issue 3, 2004, Pages 461-465

  Calza, Leonardo ^a   D'Antuono, Antonietta ^a   Marinacci, Ginevra ^a   Manfredi, Roberto ^a   Colangeli, Vincenzo ^a   Passarini, Beatrice ^a   Orioli, Roberto ^a   Varoli, Ornella ^a   Chiodo, Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; INDINAVIR; ITRACONAZOLE; LAMIVUDINE; NELFINAVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ABUSE; LEISHMANIA; MALE; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

EID: 1542344327     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.10.005     Document Type: Article

References (23)

1. Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.
2. Mondain-Miton V, Toussaint-Gari M, Hofman P, Marty P, Carles M, De Salvador F, et al. Atypical leishmaniasis in a patient with human immunodeficiency virus. Clin Infect Dis 1995;21:663-5.
3. Agostoni C, Dorigoni N, Malfitano A, Caggese L, Marchetti G, Corona S, et al. Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical and diagnostic features of 22 cases. Infection 1998;26:93-9.
4. Manfredi R, D'Antuono A, Passarini B, Neri I, Lehmann J, Mastroianni A, et al. Atypical, cutaneous leishmaniasis with suspected visceral involvement in a patient with severe HIV-related immunodeficiency. Eur J Dermatol 1996;6:350-2.
5. Ara M, Maillo C, Peon G, Clavel A, Cuesta J, Grasa MP, et al. Visceral leishmaniasis with cutaneous lesions in a patient infected with human immunodeficiency virus, Br J Dermatol 1998;139:114-7.
6. + T-lymphocyte count. AIDS 1998;12:2147-53.
7. Rosenthal E, Many P, Ie Fichoux Y, Cassuto JP. Clinical manifestations of visceral leishmaniasis associated with HIV infection: a retrospective study of 91 French cases. Ann Trop Med Parasitol 2000;94:37-42.
8. Herrera E, Sanchez P, Bosch RJ. Disseminated cutaneous leishmaniasis in an HIV-infected patient. Int J STD AIDS 1995;6:125-6.
9. Borges AS, Machado AA, Ferreira MS, de Castro Figuereido JF, Silva GF, Cimerman S, et al. Concurrent leishmaniasis and human immunodeficiency virus (HIV) infection: a study of 4 cases. Rev Soc Bras Med Trop 1999;32:713-9.
10. Mattos M, Caiza A, Fernandes O, Goncalves AJ, Pirmez C, Souza CS, et al. American cutaneous leishmaniasis associated with HIV infection: report of 4 cases. J Eur Acad Dermatol Venereol 1998;10:218-25.
11. Miralles ES, Nunez M, Hilara Y, Harto A, Moreno R, Ledo A. Mucocutaneous leishmaniasis and HIV. Dermatology 1994;189:275-7.
12. De Souza e Souza I, Naiff RD, Guimaraes TC, Naiff MF, Cupolillo E, Rodfigues WA, et al. American cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis as an initial clinical presentation of human immunodeficiency virus infection. J Eur Acad Dermatol Venereol 1998;10:214-7.
13. Colebunders R, Depraetere K, Verstraeten T, Lambert J, Hauben E, Van Marck E, et al. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection. J Am Acad Dermatol 1999;41:847-50.
14. Laguna F, Lopez-Velez R, Pulido F, Salas A, Torre-Cisneros J, Torres E, et al. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. AIDS 1999;13:1063-9.
15. Davidson RN. Practical guide for treatment of leishmaniasis. Drugs 1998;56:1009-18.
16. Berhe N, Wolday D, Hailu A, Abraham Y, Ali A, Gebre-Michael T, et al. HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS 1999;13:1921-5.
17. Mastroianni CM, d'Ettorre G, Forcina G, Corpolongo A, Dell'Isola S, Lichtner M, et al. Long-term remission of human immunodeficiency virus-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: report of two cases. J Infect 2000;40:94-6.
18. Borrelli P, Imperato A, Murdaca G, Scudeletti M. Liposomal amphotericin B as a first line and secondary prophylactic treatment for visceral leishmaniasis in a patient with HIV. Ann Ital Med Int 2000;15:169-71.
19. Hennequin C. Prevention of parasitic infection (excluding toxoplasmosis) in immunocompromised patients. Ann Med Interne (Paris) 1997;148:240-5.
20. Ribera E, Ocana I, de Otero J, Cortes E, Gasser I, Pahissa A. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Am J Med 1996;100:496-501.
21. Orlando G, Del Sorbo F, Corbellino M, Schiavini M, Cargnel A. Secondary prophylaxis for Leishmania infection in an HIV-positive patient. AIDS 1998;12:2086-7.
22. Perez-Molina JA, Lopez-Velez R, Montilla P, Guerrero A. Pentamidine isethionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients. AIDS 1996;10:237-8.
23. Angarano G, Maggi P, Coppola SL, Cavaliere RL. Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1998;17:365-7.